| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2005PNAS..102.8996P |
| P356 | DOI | 10.1073/PNAS.0409478102 |
| P932 | PMC publication ID | 1157014 |
| P698 | PubMed publication ID | 15956195 |
| P5875 | ResearchGate publication ID | 7787036 |
| P50 | author | José A. Melero | Q41481214 |
| Ruth A Karron | Q92344448 | ||
| P2093 | author name string | R Michael Hendry | |
| Pablo M Irusta | |||
| Peter L Collins | |||
| Fernando P Polack | |||
| Steven R Kleeberger | |||
| Guillermina A Melendi | |||
| Bhagvanji Thumar | |||
| Scott J Hoffman | |||
| Federico R Laham | |||
| M Florencia Delgado | |||
| M Paula Schiatti | |||
| P2860 | cites work | SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling | Q24316441 |
| Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin | Q28306447 | ||
| Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection | Q28509078 | ||
| Modulation of Th1 activation and inflammation by the NF-kappaB repressor Foxj1 | Q28586535 | ||
| Environmental exposure to endotoxin and its relation to asthma in school-age children | Q29614294 | ||
| Toll-like receptors and innate immunity | Q29615458 | ||
| Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection | Q30308018 | ||
| Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation | Q33708904 | ||
| Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse | Q33807265 | ||
| Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus | Q33848810 | ||
| Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV. | Q34151000 | ||
| The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins | Q34337480 | ||
| The central conserved cystine noose of the attachment G protein of human respiratory syncytial virus is not required for efficient viral infection in vitro or in vivo | Q34340452 | ||
| Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families | Q35533594 | ||
| A role for immune complexes in enhanced respiratory syncytial virus disease | Q36371267 | ||
| Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins. | Q36782773 | ||
| Immunity and immunopathology to respiratory syncytial virus. The mouse model | Q40408360 | ||
| Tumor necrosis factor (TNF) receptor shedding controls thresholds of innate immune activation that balance opposing TNF functions in infectious and inflammatory diseases | Q40528753 | ||
| IL-13 is sufficient for respiratory syncytial virus G glycoprotein-induced eosinophilia after respiratory syncytial virus challenge | Q40671941 | ||
| Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo | Q40771213 | ||
| Different patterns of cytokine induction in cultures of respiratory syncytial (RS) virus-specific human TH cell lines following stimulation with RS virus and RS virus proteins | Q41187648 | ||
| Loss of conserved cysteine residues in the attachment (G) glycoprotein of two human respiratory syncytial virus escape mutants that contain multiple A-G substitutions (hypermutations). | Q42673660 | ||
| CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein | Q43690717 | ||
| Respiratory syncytial virus deficient in soluble G protein induced an increased proinflammatory response in human lung epithelial cells | Q44237000 | ||
| Prolonged production of TNF-alpha exacerbates illness during respiratory syncytial virus infection | Q45598082 | ||
| Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease | Q45640302 | ||
| Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways | Q45730326 | ||
| Adaptive immune responses of patients with asthma to the attachment (G) glycoprotein of respiratory synctial virus | Q45734212 | ||
| Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus | Q45739890 | ||
| Structural homology of the central conserved region of the attachment protein G of respiratory syncytial virus with the fourth subdomain of 55-kDa tumor necrosis factor receptor. | Q45756429 | ||
| Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections | Q78439420 | ||
| P433 | issue | 25 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endotoxins | Q319997 |
| respiratory syncytial virus | Q1052913 | ||
| modulation by virus of host process | Q14818042 | ||
| RSV major surface glycoprotein G | Q24784703 | ||
| P304 | page(s) | 8996-9001 | |
| P577 | publication date | 2005-06-14 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin | |
| P478 | volume | 102 |
| Q37157161 | A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction |
| Q34547769 | A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation |
| Q35672138 | A member of the cathelicidin family of antimicrobial peptides is produced in the upper airway of the chinchilla and its mRNA expression is altered by common viral and bacterial co-pathogens of otitis media |
| Q37252613 | A respiratory syncytial virus (RSV) anti-G protein F(ab')2 monoclonal antibody suppresses mucous production and breathing effort in RSV rA2-line19F-infected BALB/c mice |
| Q34647754 | Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus |
| Q36949797 | An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats |
| Q35893983 | An anti-G protein monoclonal antibody treats RSV disease more effectively than an anti-F monoclonal antibody in BALB/c mice |
| Q36005114 | Antibodies to the central conserved region of respiratory syncytial virus (RSV) G protein block RSV G protein CX3C-CX3CR1 binding and cross-neutralize RSV A and B strains |
| Q28387231 | Antiviral activity of Nrf2 in a murine model of respiratory syncytial virus disease |
| Q45403775 | Atypical measles and enhanced respiratory syncytial virus disease (ERD) made simple |
| Q59358796 | Beyond Channel Activity: Protein-Protein Interactions Involving Viroporins |
| Q36255118 | CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells. |
| Q33754172 | Conserved cysteine residues within the attachment G glycoprotein of respiratory syncytial virus play a critical role in the enhancement of cytotoxic T-lymphocyte responses |
| Q34624688 | Development of a reverse genetics system for respiratory syncytial virus long strain and an immunogenicity study of the recombinant virus |
| Q26782411 | Development of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genes |
| Q33881536 | Effects of anti-g and anti-f antibodies on airway function after respiratory syncytial virus infection |
| Q115694808 | Functional Features of the Respiratory Syncytial Virus G Protein |
| Q38267482 | Gene sequence variability of the three surface proteins of human respiratory syncytial virus (HRSV) in Texas |
| Q116189036 | How RSV Proteins Join Forces to Overcome the Host Innate Immune Response |
| Q38065925 | Human metapneumovirus antagonism of innate immune responses |
| Q39532133 | Human metapneumovirus glycoprotein G inhibits TLR4-dependent signaling in monocyte-derived dendritic cells |
| Q21090523 | Human metapneumovirus glycoprotein G inhibits innate immune responses |
| Q59359632 | Human respiratory syncytial virus: pathogenesis, immune responses, and current vaccine approaches |
| Q34069182 | Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment protein |
| Q35948067 | Identification of a novel virulence factor in recombinant pneumonia virus of mice |
| Q35625850 | Immunological, Viral, Environmental, and Individual Factors Modulating Lung Immune Response to Respiratory Syncytial Virus. |
| Q39282294 | Induction of IL-6 and CCL5 (RANTES) in human respiratory epithelial (A549) cells by clinical isolates of respiratory syncytial virus is strain specific |
| Q59355977 | Interactive effects of age and respiratory virus on severe lower respiratory infection |
| Q34330690 | Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease |
| Q39154023 | Modulation of the host immune response by respiratory syncytial virus proteins |
| Q42211489 | Molecular characterization of human respiratory syncytial virus subtype B: a novel genotype of subtype B circulating in China |
| Q40301155 | Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective |
| Q33352424 | Parasites induced skin allergy: a strategic manipulation of the host immunity |
| Q35913930 | Partial Attenuation of Respiratory Syncytial Virus with a Deletion of a Small Hydrophobic Gene Is Associated with Elevated Interleukin-1β Responses |
| Q35566601 | Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years |
| Q34262180 | Prophylaxis with a respiratory syncytial virus (RSV) anti-G protein monoclonal antibody shifts the adaptive immune response to RSV rA2-line19F infection from Th2 to Th1 in BALB/c mice |
| Q28291028 | Protein-protein interactions and membrane localization of the human organic solute transporter |
| Q33635085 | Recombinant bovine respiratory syncytial virus with deletion of the SH gene induces increased apoptosis and pro-inflammatory cytokines in vitro, and is attenuated and induces protective immunity in calves. |
| Q36593301 | Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review |
| Q41838015 | Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses |
| Q36530226 | Respiratory syncytial virus and innate immunity: a complex interplay of exploitation and subversion |
| Q37340656 | Respiratory syncytial virus-induced dysregulation of expression of a mucosal beta-defensin augments colonization of the upper airway by non-typeable Haemophilus influenzae |
| Q36692791 | Respiratory syncytial virus: virology, reverse genetics, and pathogenesis of disease |
| Q36483809 | Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection |
| Q39963611 | Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction. |
| Q42205882 | Structural insights into the human metapneumovirus glycoprotein ectodomain. |
| Q63976654 | Sublingual Immunization With an RSV G Glycoprotein Fragment Primes IL-17-Mediated Immunopathology Upon Respiratory Syncytial Virus Infection |
| Q38086713 | Th17 lymphocytes in respiratory syncytial virus infection. |
| Q37776665 | The Battle between Virus and Host: Modulation of Toll-Like Receptor Signaling Pathways by Virus Infection |
| Q38367554 | The Pneumovirinae fusion (F) protein: A common target for vaccines and antivirals |
| Q34651258 | The cysteine-rich region and secreted form of the attachment G glycoprotein of respiratory syncytial virus enhance the cytotoxic T-lymphocyte response despite lacking major histocompatibility complex class I-restricted epitopes |
| Q37263779 | The host response and molecular pathogenesis associated with respiratory syncytial virus infection |
| Q37585325 | The regulation of type I interferon production by paramyxoviruses. |
| Q38068469 | The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development. |
| Q36994686 | The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes |
| Q34603346 | Therapeutic targeting of respiratory syncytial virus G-protein. |
| Q37072079 | Understanding the mechanisms of viral induced asthma: new therapeutic directions |
| Q47549703 | Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses |
| Q36483836 | Viral and host factors in human respiratory syncytial virus pathogenesis |
| Q36926779 | Viral stress-inducible genes. |
| Q60046445 | Viral-Induced Enhanced Disease Illness |
| Q37619850 | Virus infection facilitates the development of severe pneumonia in transplant patients with hematologic malignancies |
Search more.